CMND
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Clearmind announces publication of a Japanese patent covering treatment for neurological movement disordersOct 8, 2026
- Clearmind Medicine advances discussions with the U.S. government on psychedelic therapies and submits recommendations to the FDAOct 7, 2026
- SciSparc says its NeuroThera subsidiary strengthened its U.S. patent portfolio through a collaboration with Clearmind covering LSD, ketamine and ibogaine combinationsSep 23, 2026
- Clearmind strengthens its U.S. IP portfolio with three published patent applications covering LSD, ketamine and ibogaine combinationsSep 23, 2026
- Clearmind Medicine briefed the FDA following an invitation to a historic psychedelic hearing in Washington, D.C.Sep 17, 2026